您要查找的是不是：
- Cisapride was effective in the treatment of DGP patients. 西沙必利是治療DGP的有效藥物。
- Results:Different dose of SD and Cisapride could pro... 結果:3組中藥及西沙必利均能促進(jìn)胃腸運動(dòng)。
- Methods: 845 patients were divided into 3 groups.Then treated them with ZLD, prepulsid and primperan. 方法:將845例功能性消化不良的患者分為3組,分別用術(shù)芍連防湯、普瑞博思、胃復安治療。
- Objective To observe the effect of Cisapride on postoperative colonic peristalsis. 目的觀(guān)察西沙比利對結腸術(shù)后腸運動(dòng)功能的影響。
- Cisapride should be added as adjunct treatment in postoperative caner after colonectal surgery. 結論西沙比利可以促進(jìn)結腸手術(shù)后腸蠕動(dòng)的恢復，加快患者術(shù)后康復。
- Cisapride administration in DGP can improve gastric motility and decrease MTL concentration. 西沙比利在改善糖尿病患者M(jìn)MC的同時(shí) ,使MTL降低。
- Objective:To evaluate the therapeutic effect of cisapride on diabetic gastroparesis (DGP). 目的 :探討全胃腸道促動(dòng)力藥物西沙必利對糖尿病性胃輕癱 (DGP)的治療作用。
- Cisapride, which can reduce total and segmental CTT, is an effective drug in chronic functional constipation. 西沙必利能顯著(zhù)縮短慢性功能性便秘患者的全結腸及各節段結腸轉運時(shí)間，可常規用于慢性功能性便秘患者。
- Cisapride and mucosa protective agent should be added for patients with RE with acid and base reflux. 對有酸、堿反流的RE應加用西沙必利和粘膜保護劑。
- Conclusion:Cisapride and romitidine were more national, basic level-suiting treating drug for RE. 結論：西沙必利、雷尼替丁是較為理想的治療輕、中度RE的藥物。
- Results\ Prepulsid and Chaizhi Mixture could distinctly accelerate the evacuation and improve the propulsive function of mic... 結果普瑞博思和柴枳合劑可明顯促進(jìn)胃排空和小腸推進(jìn),阿托品和芍甘合劑則有明顯抑制作用。
- The groups were dealt with high, medium and low dosages of Leweiyin, with Cisapride and with Xiangshaliujun Pill. 分別給予高中低劑量樂(lè )胃飲、西沙必利、香砂六君丸,放免法測定血清胃泌素和血漿胃動(dòng)素。
- Treatment group(34 cases)was treated with Shenghong pill,and control group(36 cases)with Cisapride. 治療組34例用勝紅丸加減治療,對照組36例用西沙必利治療,其它治療方法兩組相同,療程2周。
- Conclusion: Combination of omeptazole and cisapride is more effective on the treatment of esophagitis. 結論：洛賽克與西沙比利聯(lián)合使用治療反流性食管炎效果較好。
- As a new type of gastroenteric prokinetic drug, mosapride citrate tablet is more prospective than domperidone and cisapride to treat DGP. 枸櫞酸莫沙必利片是一種比嗎丁啉片、西沙必利片更有前途的治療 DGP的新型促消化道動(dòng)力藥
- Three months later, group DM were divided into three groups: DGP(group D, 20), therapy of Cisapride(group X, 20) and Atropine test(group A, 20). 3個(gè)月后再將DM組分為DGP組(D組)、西沙必利治療組(X組)和阿托品試驗組(A組),每組各20只。
- Objective To study the relationship betw een functional dyspepsia ( F D) and gastric em ptying,and also the therapeutic effect of cisapride on F D. 目的探討功能性消化不良與胃排空的關(guān)系及普瑞博思的治療作用。
- Objective To investigate colonic transit time (CTT) in normal subjects and evaluate the effect of cisapride on CTT on chronic functional constipation. 目的了解國人結腸轉運時(shí)間的正常值，并探討西沙必利對慢性功能性便秘患者的結腸轉運時(shí)間(CTT)的作用。
- Objective:To compare the efficiency and economic cost of mosapride,cisapride,clebopride and domperidone in the treatment of functional dyspepsia. 目的:比較莫沙必利、西沙必利、氯波必利及多潘立酮治療功能性消化不良的療效與藥物經(jīng)濟學(xué)成本。
- Methods: 80 patients are devided into 2 groups randomly,A team uses Cisapride, B team uses Cisapride and Prozac.The treatment continue 4 weeks. 方法80例病人隨機分成兩組,A組用西沙必利治療,B組用西沙必利加百優(yōu)解,治療4周后觀(guān)察療效。
